title: Treatment of facial verrucae with topical imiquimod cream in a patient with human immunodeficiency virus.
abstract: Imiquimod is a recently developed imidazoquinolin heterocyclic amine that is an immune response modifier. Treatment with topical 5% imiquimod cream has shown promising results in the treatment of genital warts in immunocompetent individuals. We report here the first case of successful treatment with topical 5% imiquimod cream of facial verrucae in an individual with human immunodeficiency virus.
authors.affiliation: Department of Dermatology, New York Medical College-Metropolitan Hospital Center, NY, USA.
authors.forename: K
authors.initials: K
authors.lastname: Cutler
authors.forename: M H
authors.initials: MH
authors.lastname: Kagen
authors.forename: P C
authors.initials: PC
authors.lastname: Don
authors.forename: P
authors.initials: P
authors.lastname: McAleer
authors.forename: J M
authors.initials: JM
authors.lastname: Weinberg
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000175:diagnosis / Q000188:drug therapy*; D000276:Adjuvants, Immunologic / Q000008:administration & dosage*; D000287:Administration, Topical; D000328:Adult; D000634:Aminoquinolines / Q000008:administration & dosage*; D005148:Facial Dermatoses / Q000175:diagnosis / Q000188:drug therapy; D005500:Follow-Up Studies; D006801:Humans; D000077271:Imiquimod; D008297:Male; D009824:Ointments; D016896:Treatment Outcome; D014860:Warts / Q000175:diagnosis / Q000188:drug therapy*
chemical_list: D000276:Adjuvants, Immunologic; D000634:Aminoquinolines; D009824:Ointments; D000077271:Imiquimod